Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
The role of stress-response systems for the pathogenesis and progression of MS.
Anesthetic management of a parturient with neuromyelitis optica.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Review: the role of vitamin D in nervous system health and disease.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.

Pages